Obesity and demographic ageing are two global megatrends that overlap in a particularly unfavorable way in the cardiovascular system. Both factors independently increase the risk of cardiovascular disease, but also interact at common biological levels: from cellular senescence and mitochondrial dysfunction to structural cardiac and vascular remodeling. The state-of-the-art review by Ruperez et al. in the European Heart Journal sheds light on how obesity accelerates biological cardiovascular ageing, which mechanistic intersections can be found and which metabolic therapy strategies – from calorie restriction to GLP-1 receptor agonists and SGLT2 inhibitors – can modulate these processes.
Autoren
- Tanja Schliebe
Publikation
- CARDIOVASC
Related Topics
You May Also Like
- Lung cancer
Multidisciplinary teams in oncology
- Diagnostics of respiratory viral infections
What is tested when and on whom?
- Seborrheic dermatitis in adults
Do not underestimate the symptom burden
- SGLT2 inhibitors
Clear, simple language improves patient safety
- Moderate to severe atopic dermatitis
Established and novel biologics – the therapeutic landscape is in flux
- Recognize CKD early and avoid dialysis
Screen diabetics and hypertensive patients regularly and use modern therapies
- From symptom to diagnosis
Abdominal pain – Inguinal testicles
- Case series